Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells

Published:2007-05 Issue:2 Volume:3 Page:89-95
ISSN:1551-1286
Container-title:NanoBiotechnology
language:en
Short-container-title:Nanobiotechnol

Author:

Lu Jie,Liong Monty,Sherman Sean,Xia Tian,Kovochich Michael,Nel Andre E.,Zink Jeffrey I.,Tamanoi Fuyuhiko

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Biomedical Engineering,Bioengineering

Link

http://link.springer.com/content/pdf/10.1007/s12030-008-9003-3.pdf

Reference24 articles.

1. Reynolds AR, Moein MS, Hodivala-Dilke K. Trends Mol Med 2003;9:2–4.

2. Van Vlerken LE, Amiji MM. Expert Opin Drug Deliv 2006;3:205–16.

3. Ebbesen M, Jensen TG. J Biomed Biotechnol 2006;2006:51516.

4. Brannon-Peppas L, Blanchette JO. Adv Drug Deliv Rev 2004;56:1649–59.

5. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Nature 1992;359:710–2.

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the nano-Frontier: revolutionizing lung cancer diagnosis and therapy with nanoparticles;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-06-18

2. Mesoporous silica nanoparticles as a drug delivery mechanism;Open Life Sciences;2024-01-01

3. Nanozymes: a new approach for leukemia therapy;Journal of Materials Chemistry B;2024

4. Nanomaterials as Theranostic Agents for Cancer Therapy;ACS Applied Nano Materials;2023-11-29

5. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study;Advanced Therapeutics;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3